Shockwave Medical (Nasdaq:SWAV) announced today that it opened a new production plant for its intravascular lithotripsy (IVL) technology in Costa Rica. The company shared news of the new plant, located in San José, in a post on LinkedIn. It marks another recent positive development for the company, which agreed to be acquired for $13.1 billion by […]
Illumina CFO departs, replacement named along with chief strategy officer
Illumina (Nasdaq:ILMN) announced that it appointed Ankur Dhingra as CFO following the departure of Joydeep Goswami. The company also announced the appointment of Jakob Wedel as chief strategy and corporate development officer. Its c-suite continues to undergo a makeover following the appointment of a new CEO last year amid its long-running battle to acquire Grail. Goswami, […]
Biotronik unveils new AI-powered insertable cardiac monitor
Biotronik announced that it received CE mark approval and completed the first European implant of its latest insertable cardiac monitor (ICM). The BioMonitor IV features AI capabilities for false positive reduction. The AI cuts false positives for AFib, bradycardia, tachycardia and pause. According to Biotronik, its SmartECG reduces 86% of false detections across all major […]
Medtronic unveils next-gen GI Genius software, partners with ModMed on AI-powered colonoscopy
Medtronic today announced advancements for its AI-powered GI Genius system, as well as a new collaboration. The company unveiled its ColonPRO latest-generation software for the GI Genius intelligent endoscopy system. GI Genius, a computer-aided polyp detection system powered by AI, has been available in the U.S. since 2021. Medtronic designed it to redefine GI screening by […]
Philips comes to consent decree agreement with DOJ, FDA over Respironics recall
Philips today announced a final agreement on a consent decree with the FDA and U.S. Dept. of Justice (DOJ). The consent decree primarily focuses on its Philips’ Pennsylvania-based Respironics business — the subject of a major recall over the past several years. That includes manufacturing facilities in Murrysville and New Kensington, a service center in […]
OM1, Medtronic partner on drug-eluting implant study
OM1 today announced positive results from its partnership with Medtronic (NYSE:MDT) evaluating the Propel corticosteroid-eluting implants. The Propel bioabsorbable implant family came to Medtronic through its acquisition of IntersectENT in 2022. OM1 and Medtronic partnered on their study to focus on healthcare resource use and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent […]
J&J’s DePuy Synthes launches new spine screw system
Johnson & Johnson’s DePuy Synthes orthopedic unit today announced plans to showcase new advancements across its spine portfolio. The company plans to show the offerings at the 31st International Meeting on Advance Spine Techniques (IMAST) 2024 this week. Notably, the company plans to unveil its next-generation TriAltis spine system. The posterior thoracolumbar pedicle screw system […]
Biosense Webster reports positive dual-energy ablation results
Johnson & Johnson’s Biosense Webster unit today announced positive three-month follow-up results from its SmartfIRE clinical trial. The study evaluated the use of the dual-energy ThermoCool SmartTouch SF catheter. ThermoCool SmartTouch SF is the first dual-energy pulsed field ablation (PFA)/radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index. Biosense Webster’s system in […]
Proprio, Biedermann partner on AI-powered spine surgery
Proprio announced today that it entered into a multi-phase partnership with the Biedermann Group to integrate AI into spine implants. Initially, the companies want to integrate Biedermann’s advanced spinal implant’s with Proprio’s Paradigm system. Paradigm harnesses AI, computer vision and augmented reality to provide real-time surgical visualization and guidance. Seattle-based Proprio designed the Paradigm surgical […]
Shockwave Medical has positive Reducer data
Shockwave Medical (Nasdaq:SWAV) announced positive six-month and long-term real-world outcomes for its Reducer technology. Investigators presented data at the American College of Cardiology (ACC) Scientific Sessions in Atlanta. Results included six-month data from the full REDUCER-I population and interim long-term follow-up results out to three years. According to Shockwave, results confirm the positive real-world outcomes […]
Outset Medical stock soars on optimistic analyst outlook
Outset Medical shares are on the rise after BTIG analysts initiated coverage with a “Buy” rating for the home hemodialysis company. Shares of OM rose by more than 25% to $2.58 apiece in late-afternoon trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The optimistic outlook […]